11 – 20 of 168
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial
- Contribution to journal › Debate/Note/Editorial
-
Mark
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
- Contribution to journal › Article
-
Mark
Heterogeneous Challenges for Urologic Cancers.
- Contribution to journal › Debate/Note/Editorial
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
- Contribution to journal › Scientific review
-
Mark
Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial.
- Contribution to journal › Article
-
Mark
Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer.
- Contribution to journal › Article
-
Mark
Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy.
- Contribution to journal › Article
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
- Contribution to journal › Article
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
- Contribution to journal › Article
-
Mark
Targeting the Mechanisms of Progression in Castration-resistant Prostate Cancer.
- Contribution to journal › Debate/Note/Editorial
